Home » Topics » Regulatory, BioWorld Science

Regulatory, BioWorld Science
RSS

FDA approves amprenavir, first new protease inhibitor in more than two years

April 19, 1999

Higher dose of Rebif approved in E.U. for multiple sclerosis

April 15, 1999

In vitro and in vivo antitumor effects of noscapine discussed at AACR meeting

April 15, 1999

FDA approves Fragmin for DVT after hip replacement surgery

April 13, 1999

SangStat's ciclosporin capsules filed for approval in U.K.

April 12, 1999

First launch for RiboGene's intranasal metoclopramide

April 8, 1999

FDA approves ANDA for Oruvail

April 7, 1999

FDA approval granted for BioTime's blood plasma volume expander

April 6, 1999

Zeneca files sNDA for change in dosing for Zestril

April 6, 1999

FDA approves DepoCyt for treatment of lymphomatous meningitis

April 6, 1999

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...